title: In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
abstract: Simian virus 40 (SV40) contains an essential protein, large tumor antigen (Tag), which assists in viral replication and causes cell transformation and immortalization. Our laboratory has examined plasmid DNA, expressing SV40 Tag under two different promoters, for use in potential cancer vaccination strategies. One plasmid, pSV3-neo, failed to induce SV40 Tag antibody, produced a weak cell-mediated response, and only partial protection in murine experimental tumor challenge systems. The second plasmid, pCMV-Tag, induced antibodies to SV40 Tag, produced a robust cell-mediated response, and invoked complete tumor immunity in vivo. The induction of CD4+ and CD8+ T cell responses following plasmid DNA immunization and tumor cell challenge reflected a type 1 cytokine secretion profile. Our hypothesis for this differential immune response is that pCMV-Tag exhibits a higher level of transgene expression due to a more efficient promoter. We determined that pCMV-Tag levels of SV40 Tag mRNA and protein expression were higher when compared to pSV3-neo. A threshold amount of SV40 Tag may be required to stimulate antibody production and provide complete systemic tumor immunity.
authors.affiliation: Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street STOP 6591, Lubbock, TX 79430-9562, USA.
authors.forename: Devin B
authors.initials: DB
authors.lastname: Lowe
authors.forename: Michael H
authors.initials: MH
authors.lastname: Shearer
authors.forename: James A
authors.initials: JA
authors.lastname: Tarbox
authors.forename: Hyun Seok
authors.initials: HS
authors.lastname: Kang
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Jumper
authors.forename: Robert K
authors.initials: RK
authors.lastname: Bright
authors.forename: Ronald C
authors.initials: RC
authors.lastname: Kennedy
mesh_terms: D000818:Animals; D000912:Antibodies, Neoplasm / Q000096:biosynthesis / Q000276:immunology; D000952:Antigens, Polyomavirus Transforming / Q000276:immunology*; D000956:Antigens, Viral / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002461:Cell Line, Transformed; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D012513:Sarcoma, Experimental / Q000276:immunology; D013539:Simian virus 40 / Q000276:immunology*; D019444:Vaccines, DNA / Q000276:immunology*
chemical_list: D000912:Antibodies, Neoplasm; D000952:Antigens, Polyomavirus Transforming; D000956:Antigens, Viral; D019444:Vaccines, DNA